This study provided further solid evidence that CA XII inhibitors, when used in combination with Pgp substrate drugs, overcome Pgp-mediated drug resistance in CA XII+ve/Pgp+ve cancer cells, a typical phenotype of aggressive and drug resistant tumors of different tissue origins. This evidence concerns the gene CA12 and cancer.